Detalhe da pesquisa
1.
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
N Engl J Med
; 390(15): 1394-1407, 2024 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587233
2.
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
N Engl J Med
; 389(12): 1069-1084, 2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37622681
3.
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Lancet
; 403(10437): 1635-1648, 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599221
4.
Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial.
Circulation
; 148(11): 862-871, 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37555345
5.
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
Lancet
; 400(10369): 2199-2209, 2022 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36347265
6.
The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction.
J Card Fail
; 2023 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926238
7.
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial.
Eur Heart J
; 42(6): 684-696, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33215209
8.
Misdiagnosis of Heart Failure: A Systematic Review of the Literature.
J Card Fail
; 27(9): 925-933, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34048921
9.
Cost-Effectiveness Analyses of an Absorbable Antibacterial Envelope for Use in Patients at Increased Risk of Cardiac Implantable Electronic Device Infection in Germany, Italy, and England.
Value Health
; 24(7): 930-938, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34243836
10.
Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score.
Europace
; 23(9): 1446-1455, 2021 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33755136
11.
Metal artefact reduction algorithms prevent false positive results when assessing patients for cardiac implantable electronic device infection.
J Nucl Cardiol
; 22(1): 219-20, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25112539
12.
Pacing-induced cardiomyopathy: pathophysiological insights through matrix metalloproteinases.
Heart Fail Rev
; 19(5): 669-80, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23856884
13.
Patient radiation dose during fluoroscopically guided biventricular device implantation.
Acta Cardiol
; 69(5): 491-5, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25638836
14.
Not all pacemakers are created equal: MRI conditional pacemaker and lead technology.
J Cardiovasc Electrophysiol
; 24(9): 1059-65, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24016320
15.
Prolylcarboxypeptidase Alleviates Hypertensive Cardiac Remodeling by Regulating Myocardial Tissue Angiotensin II.
J Am Heart Assoc
; 12(12): e028298, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37318028
16.
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial.
Nat Med
; 29(9): 2358-2365, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37635157
17.
A Systematic Review, Meta-Analysis, and Indirect Comparison of Blindly Adjudicated Cardiovascular Event Incidence with Ferric Derisomaltose, Ferric Carboxymaltose, and Iron Sucrose.
Adv Ther
; 39(10): 4678-4691, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947351
18.
A Critical Evaluation of Patient Pathways and Missed Opportunities in Treatment for Heart Failure.
J Cardiovasc Dev Dis
; 9(12)2022 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36547452
19.
Rationale and design of a randomised trial of intravenous iron in patients with heart failure.
Heart
; 108(24): 1979-1985, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948408
20.
Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial.
ESC Heart Fail
; 9(6): 4352-4357, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36065795